AAAAAA
Results:
1-11
|
Results: 11
Authors:
Silverman, DHS
Phelps, ME
Citation: Dhs. Silverman et Me. Phelps, Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: Normal development, aging, dementia, and stroke, MOL GEN MET, 74(1-2), 2001, pp. 128-138
Authors:
Gambhir, SS
Czernin, J
Schwimmer, J
Silverman, DHS
Coleman, RE
Phelps, ME
Citation: Ss. Gambhir et al., A tabulated summary of the FDG PET literature, J NUCL MED, 42(5), 2001, pp. 1S-93S
Authors:
Silverman, DHS
Small, GW
Chang, CY
Lu, CS
de Aburto, MAK
Chen, W
Czernin, J
Rapoport, SI
Pietrini, P
Alexander, GE
Schapiro, MB
Jagust, WJ
Hoffman, JM
Welsh-Bohmer, KA
Alavi, A
Clark, CM
Salmon, E
de Leon, MJ
Mielke, R
Cummings, JL
Kowell, AP
Gambhir, SS
Hoh, CK
Phelps, ME
Citation: Dhs. Silverman et al., Positron emission tomography in evaluation of dementia - Regional brain metabolism and long-term outcome, J AM MED A, 286(17), 2001, pp. 2120-2127
Authors:
Small, GW
Ercoli, LM
Silverman, DHS
Huang, SC
Bookheimer, SY
Lavretsky, H
Miller, K
Siddarth, P
Mazziotta, JC
Saunders, AM
Pericak-Vance, MA
Roses, AD
Barrio, JR
Phelps, ME
Citation: Gw. Small et al., Influence of apoE genotype and PET brain imaging on preclinical predictionof Alzheimer's disease, ALZHEIMER'S DISEASE, 2001, pp. 193-203
Authors:
Wiseman, GA
White, CA
Stabin, M
Dunn, WL
Erwin, W
Dahlbom, M
Raubitschek, A
Karvelis, K
Schultheiss, T
Witzig, TE
Belanger, R
Spies, S
Silverman, DHS
Berlfein, JR
Ding, E
Grillo-Lopezs, AJ
Citation: Ga. Wiseman et al., Phase I/II Y-90-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma, EUR J NUCL, 27(7), 2000, pp. 766-777
Authors:
Silverman, DHS
Phelps, ME
Citation: Dhs. Silverman et Me. Phelps, Evaluating dementia using PET: How do we put into clinical perspective what we know to date?, J NUCL MED, 41(11), 2000, pp. 1929-1932
Authors:
Small, GW
Ercoli, LM
Silverman, DHS
Huang, SC
Komo, S
Bookheimer, SY
Lavretsky, H
Miller, K
Siddarth, P
Rasgon, NL
Mazziotta, JC
Saxena, S
Wu, HM
Mega, MS
Cummings, JL
Saunders, AM
Pericak-Vance, MA
Roses, AD
Barrio, JR
Phelps, ME
Citation: Gw. Small et al., Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease, P NAS US, 97(11), 2000, pp. 6037-6042
Authors:
Wiseman, GA
White, CA
Witzig, TE
Gordon, LI
Emmanouilides, C
Raubitschek, A
Janakiraman, N
Gutheil, J
Schilder, RJ
Spies, S
Silverman, DHS
Grillo-Lopez, AJ
Citation: Ga. Wiseman et al., Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with Zevalin, a Y-90-labeled anti-CD20 monoclonal antibody, CLIN CANC R, 5(10), 1999, pp. 3281S-3286S
Authors:
Brody, AL
Saxena, S
Silverman, DHS
Alborzian, S
Fairbanks, LA
Phelps, ME
Huang, SC
Wu, HM
Maidment, K
Baxter, LR
Citation: Al. Brody et al., Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine, PSYCH RES-N, 91(3), 1999, pp. 127-139
Authors:
Witzig, TE
White, CA
Wiseman, GA
Gordon, LI
Emmanouilides, C
Raubitschek, A
Janakiraman, N
Gutheil, J
Schilder, RJ
Spies, S
Silverman, DHS
Parker, E
Grillo-Lopez, AJ
Citation: Te. Witzig et al., Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsedor refractory CD20(+) B-cell non-Hodgkin's lymphoma, J CL ONCOL, 17(12), 1999, pp. 3793-3803
Authors:
Farquhar, TH
Llacer, J
Hoh, CK
Czernin, J
Gambhir, SS
Seltzer, MA
Silverman, DHS
Qi, JY
Hsu, CH
Hoffman, EJ
Citation: Th. Farquhar et al., ROC and localization ROC analyses of lesion detection in whole-body FDG PET: Effects of acquisition mode, attenuation correction and reconstruction algorithm, J NUCL MED, 40(12), 1999, pp. 2043-2052
Risultati:
1-11
|